Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Profit After Tax (2022 - 2025)

Historic Profit After Tax for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.

  • 60 Degrees Pharmaceuticals' Profit After Tax fell 724.55% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 34.87%. This contributed to the annual value of -$8.0 million for FY2024, which is 10860.2% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Profit After Tax stood at -$2.3 million for Q3 2025, which was down 724.55% from -$1.7 million recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Profit After Tax registered a high of $4.2 million during Q3 2023, and its lowest value of -$4.2 million during Q2 2024.
  • Moreover, its 4-year median value for Profit After Tax was -$2.0 million (2023), whereas its average is -$1.6 million.
  • In the last 5 years, 60 Degrees Pharmaceuticals' Profit After Tax soared by 38836.38% in 2023 and then tumbled by 53610.5% in 2025.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Profit After Tax (Quarter) stood at -$1.7 million in 2022, then dropped by 22.27% to -$2.0 million in 2023, then decreased by 0.13% to -$2.0 million in 2024, then decreased by 13.09% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q3 2025, -$1.7 million for Q2 2025, and -$1.9 million during Q1 2025.